|
Schwarz Pharma AG - Company Profile Snapshot
| Company Profile: |
Schwarz Pharma AG |
| Ticker: |
SRZ |
| Exchanges: |
DUS FRA |
| 2008 Sales: |
424,850,000 |
| Major Industry: |
Drugs, Cosmetics & Health Care |
| Sub Industry: |
Ethical Drug Manufacturers |
| Country: |
GERMANY |
| Employees: |
2126 |
Business Description
Schwarz Pharma AG. The Group's principal activity is to research, develop, manufacture and market pharmaceuticals. It involves in bulk manufacturing, packaging and material management of pharmaceutical drugs. It specializes in manufacturing solid oral dosage forms and packing with modern blister machines. It also provides raw material and packaging materials for pharmaceutical industries. The drugs are manufactured for the following concerns: Cardiovascular diseases, Gastro intestinal diseases, Urology and Central nervous system related diseases. It operates under the brand names Atmadisc, Deponit, Dycanil, Elantan, Firin, Harzol, Isoket, Naramig, Nipruss and Sita. The Group operates in Germany, Italy, the United Kingdom, the United States, Switzerland, China, Hong Kong and Philippines.
|
Not the Report you are looking for?
Click here for more browsing options.
|
The following information is available to subscribers or can be accessed by purchasing the Company Profile Report:
|
- Address (mailing), Phone Number, Web Address
- Earnings/Dividends
- Employees
- Exchanges Listed
- Financial Ratio Analysis |
- Recent Stock Performance
- Sales (recent year)
- Senior Officers
- Shareholder Information
- Stock Analysis Summary |
Layout and Content of a Typical Report
|
|
|
|
|
